skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date
Material Type:
Article
Add to My Research

Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date

Therapeutics and clinical risk management, 2020-01, Vol.16, p.681-688 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Akbar et al. 2020 Akbar et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S224772 ;PMID: 32801725

Full text available

2
Association of epicardial adipose tissue thickness and inflammation parameters with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation
Material Type:
Article
Add to My Research

Association of epicardial adipose tissue thickness and inflammation parameters with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation

Therapeutics and clinical risk management, 2015-11, Vol.11 (default), p.1675-1681 [Peer Reviewed Journal]

2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Akdag et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S94955 ;PMID: 26609234

Full text available

3
Treatment Outcomes of the Acute Coronary Syndrome Among Patients Attending St. Paul Hospital
Material Type:
Article
Add to My Research

Treatment Outcomes of the Acute Coronary Syndrome Among Patients Attending St. Paul Hospital

Therapeutics and clinical risk management, 2023-01, Vol.19, p.105-114 [Peer Reviewed Journal]

2023 Anagaw et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Anagaw et al. 2023 Anagaw et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S382422 ;PMID: 36733976

Full text available

4
Echocardiographic assessment of left ventricular function in thyrotoxicosis and implications for the therapeutics of thyrotoxic cardiac disease
Material Type:
Article
Add to My Research

Echocardiographic assessment of left ventricular function in thyrotoxicosis and implications for the therapeutics of thyrotoxic cardiac disease

Therapeutics and clinical risk management, 2015-01, Vol.11, p.189-200 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Anakwue et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S68752 ;PMID: 25709461

Full text available

5
Elevated levels of vitamin B12 in chronic stable heart failure: a marker for subclinical liver damage and impaired prognosis
Material Type:
Article
Add to My Research

Elevated levels of vitamin B12 in chronic stable heart failure: a marker for subclinical liver damage and impaired prognosis

Therapeutics and clinical risk management, 2018-01, Vol.14, p.1067-1073 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Argan et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S164200 ;PMID: 29922067

Full text available

6
Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course
Material Type:
Article
Add to My Research

Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course

Therapeutics and clinical risk management, 2014-01, Vol.10, p.825-839 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Baldi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S48920 ;PMID: 25328398

Full text available

7
Pulmonary hypertension: diagnostic and therapeutic challenges
Material Type:
Article
Add to My Research

Pulmonary hypertension: diagnostic and therapeutic challenges

Therapeutics and clinical risk management, 2015-01, Vol.11, p.1221-1233 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Bazan and Fares. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S74881 ;PMID: 26316767

Full text available

8
Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
Material Type:
Article
Add to My Research

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life

Therapeutics and clinical risk management, 2019-01, Vol.15, p.959-964 [Peer Reviewed Journal]

2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Beiko and Strange. 2019 Beiko and Strange. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S175369 ;PMID: 31534340

Full text available

9
A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial
Material Type:
Article
Add to My Research

A restrictive dose of crystalloids in patients during laparoscopic cholecystectomy is safe and cost-effective: prospective, two-arm parallel, randomized controlled trial

Therapeutics and clinical risk management, 2018-01, Vol.14, p.741-751 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Belavić et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S160778 ;PMID: 29719401

Full text available

10
Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
Material Type:
Article
Add to My Research

Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines

Therapeutics and clinical risk management, 2020-01, Vol.16, p.749-758 [Peer Reviewed Journal]

2020 Benson et al. ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Benson et al. 2020 Benson et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S185677 ;PMID: 32884276

Full text available

11
Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies
Material Type:
Article
Add to My Research

Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies

Therapeutics and clinical risk management, 2016-01, Vol.12 (Issue 1), p.887-906 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Bonsu et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S106065 ;PMID: 27350750

Full text available

12
Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania
Material Type:
Article
Add to My Research

Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania

Therapeutics and clinical risk management, 2021-01, Vol.17, p.249-258 [Peer Reviewed Journal]

2021 Bordejevic et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Bordejevic et al. 2021 Bordejevic et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S295251 ;PMID: 33790565

Full text available

13
Quality and Characteristics of 4241 Case Reports of Lactic Acidosis in Metformin Users Reported to a Large Pharmacovigilance Database
Material Type:
Article
Add to My Research

Quality and Characteristics of 4241 Case Reports of Lactic Acidosis in Metformin Users Reported to a Large Pharmacovigilance Database

Therapeutics and clinical risk management, 2022-01, Vol.18, p.1037-1047 [Peer Reviewed Journal]

2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Brand et al. 2022 Brand et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S372430

Full text available

14
Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes
Material Type:
Article
Add to My Research

Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes

Therapeutics and clinical risk management, 2014-01, Vol.10 (default), p.139-145 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Chávez-Tapia et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S59312 ;PMID: 24600229

Full text available

15
Association between hyperleptinemia and cardiovascular outcomes in patients with coronary artery disease
Material Type:
Article
Add to My Research

Association between hyperleptinemia and cardiovascular outcomes in patients with coronary artery disease

Therapeutics and clinical risk management, 2018-01, Vol.14, p.1855-1862 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Chen et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S172231 ;PMID: 30319266

Full text available

16
Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy
Material Type:
Article
Add to My Research

Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy

Therapeutics and Clinical Risk Management, 2023-01, Vol.19, p.133-142 [Peer Reviewed Journal]

2023 Colbert et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Colbert et al. 2023 Colbert et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S398163 ;PMID: 36756278

Full text available

17
Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
Material Type:
Article
Add to My Research

Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data

Therapeutics and clinical risk management, 2020-01, Vol.16, p.715-726 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Cuthbert et al. 2020 Cuthbert et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S234772 ;PMID: 32848403

Full text available

18
Copeptin: a new predictor for severe obstructive sleep apnea
Material Type:
Article
Add to My Research

Copeptin: a new predictor for severe obstructive sleep apnea

Therapeutics and clinical risk management, 2015-01, Vol.11 (default), p.589-594 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Çınarka et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S80779 ;PMID: 25914540

Full text available

19
Cardiorenal syndrome type 2: from diagnosis to optimal management
Material Type:
Article
Add to My Research

Cardiorenal syndrome type 2: from diagnosis to optimal management

Therapeutics and clinical risk management, 2014-01, Vol.10, p.949-961 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 De Vecchis and Baldi. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S63255 ;PMID: 25419141

Full text available

20
Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
Material Type:
Article
Add to My Research

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations

Therapeutics and clinical risk management, 2020-01, Vol.16, p.769-785 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Dzhioeva and Belyavskiy. 2020 Dzhioeva and Belyavskiy. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S207117 ;PMID: 32904123

Full text available

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait